Skip to Content
MilliporeSigma
  • Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog.

Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog.

Gynecologic oncology (1999-06-15)
J W Kim, Y S Lee, B K Kim, D C Park, J M Lee, I K Kim, S E Namkoong
ABSTRACT

Gonadotropin-releasing hormone (GnRH) has been shown to have an inhibitory effect on the growth of several hormone-dependent human tumors. We have treated a human endometrial cancer cell line which expresses GnRH receptor with GnRH analog, D-Trp6-LHRH, in order to study whether there are differences in cell cycle kinetic response. Flow cytometric analysis revealed that cultured carcinoma cells showed a cell cycle arrest at the G1-S transition after treatment with 10 microM D-Trp6-LHRH for 36 h. Western blot analysis showed that the level of p16 protein was obvious following 24 h of D-Trp6-LHRH treatment. These results suggest that the mechanism by which GnRH inhibits the growth of endometrial carcinoma cells may include effects on cell cycle arrest.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
[D-Trp6]-LH-RH, ≥97% (HPLC), powder